Real-time product attribute control to manufacture antibodies with defined N-linked glycan levels

Pressures for cost‐effective new therapies and an increased emphasis on emerging markets require technological advancements and a flexible future manufacturing network for the production of biologic medicines. The safety and efficacy of a product is crucial, and consistent product quality is an esse...

Ausführliche Beschreibung